1
|
Naguy A. Gepirone-the latest antidepressant on market state-of-the-art or run-of-the-mill? Asian J Psychiatr 2024; 94:103937. [PMID: 38335641 DOI: 10.1016/j.ajp.2024.103937] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/04/2023] [Accepted: 01/31/2024] [Indexed: 02/12/2024]
Abstract
Gepirone was recently launched and FDA-approved for MDD. It belongs to azapirones group of psychotropics that is in popular use in Japan and China. Here, author wraps up current knowledge on gepirone contrasted with the older and cheaper anxiolytic buspirone.
Collapse
Affiliation(s)
- Ahmed Naguy
- Psychiatrist, Kuwait Centre for Mental Health (KCMH), State of Kuwait.
| |
Collapse
|
2
|
George S, Joy R, Roy A. Drug-Induced Bruxism: a Comprehensive Literature Review. JOURNAL OF ADVANCED ORAL RESEARCH 2021. [DOI: 10.1177/2320206821992534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Bruxism is a parafunctional teeth grinding activity that is attributed to be of multifactorial origin. The aim of this article is to provide a brief overview on drug-induced bruxism, commonly associated drugs, and its possible pathogenic mechanisms. Around 43 relevant publications were selected after a comprehensive search in PubMed, Cochrane library, Science Direct, and Google Scholar with appropriate keywords to collect data and compile this review. Disturbances in the neurotransmitters and their receptors in the central nervous system may play a significant role, particularly in sleep bruxism. Drugs that interfere normal secretion and function of neurotransmitters are documented to be capable of inducing bruxism. Such psychotropic drugs are being used in clinical practice chiefly for the management of mood disorders, anxiety, and depression. Although bruxism is a well-recognized side effect of certain medications, the extent of awareness about the same is still inadequate among dental professionals.
Collapse
Affiliation(s)
- Sosa George
- Department of Oral Medicine and Radiology, Meenakshi Ammal Dental College, Chennai, Tamil Nadu, India
| | - Rini Joy
- Department of Oral Medicine and Radiology, SRM Dental College and Hospital, Chennai, Tamil Nadu, India
| | - Anitha Roy
- Faculty of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
| |
Collapse
|
3
|
de Baat C, Verhoeff M, Ahlberg J, Manfredini D, Winocur E, Zweers P, Rozema F, Vissink A, Lobbezoo F. Medications and addictive substances potentially inducing or attenuating sleep bruxism and/or awake bruxism. J Oral Rehabil 2020; 48:343-354. [PMID: 32716523 PMCID: PMC7984358 DOI: 10.1111/joor.13061] [Citation(s) in RCA: 49] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2020] [Revised: 05/30/2020] [Accepted: 07/16/2020] [Indexed: 12/22/2022]
Abstract
Bruxism is a repetitive jaw‐muscle activity characterised by clenching or grinding of the teeth and/or by bracing or thrusting of the mandible. It can occur during sleep, indicated as sleep bruxism, or during wakefulness, indicated as awake bruxism. Exogenous risk indicators of sleep bruxism and/or awake bruxism are, among others, medications and addictive substances, whereas also several medications seem to have the potential to attenuate sleep bruxism and/or awake bruxism. The objective of this study was to present a narrative literature on medications and addictive substances potentially inducing or aggravating sleep bruxism and/or awake bruxism and on medications potentially attenuating sleep bruxism and/or awake bruxism. Literature reviews reporting evidence or indications for sleep bruxism and/or awake bruxism as an adverse effect of several (classes of) medications as well as some addictive substances and literature reviews on medications potentially attenuating sleep bruxism and/or awake bruxism were used as starting point and guidelines to describe the topics mentioned. Additionally, two literature searches were established on PubMed. Three types of bruxism were distinguished: sleep bruxism, awake bruxism and non‐specified bruxism. Generally, there are insufficient evidence‐based data to draw definite conclusions concerning medications and addictive substances inducing or aggravating sleep bruxism and/or awake bruxism as well as concerning medications attenuating sleep bruxism and/or awake bruxism. There are insufficient evidence‐based data to draw definite conclusions concerning medications and addictive substances inducing or aggravating sleep bruxism and/or awake bruxism as well as concerning medications attenuating sleep bruxism and/or awake bruxism.
Collapse
Affiliation(s)
- Cees de Baat
- Foundation for Oral Health and Parkinson's Disease, Oegstgeest, The Netherlands.,Fresh Unieke Mondzorg, Woerden, The Netherlands.,Department of Oral Function and Prosthetic Dentistry, Radboud university medical center, Nijmegen, The Netherlands
| | - Merel Verhoeff
- Department of Orofacial Pain and Dysfunction, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Jari Ahlberg
- Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland
| | - Daniele Manfredini
- Department of Biomechanical Diseases, School of Dentistry, University of Siena, Siena, Italy
| | - Ephraim Winocur
- Department of Oral Rehabilitation, Dental School, Tel Aviv University, Tel Aviv, Israel
| | - Petra Zweers
- Netherlands pharmacovigilance centre LAREB, Hertogenbosch, The Netherlands
| | - Fred Rozema
- Department of Oral Medicine, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.,Department of Oral and Maxillofacial Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
| | - Arjan Vissink
- Department of Oral and Maxillofacial Surgery, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
| | - Frank Lobbezoo
- Foundation for Oral Health and Parkinson's Disease, Oegstgeest, The Netherlands.,Department of Orofacial Pain and Dysfunction, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| |
Collapse
|